Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF)

Sied Kebir, Christoph Oster, Sandeep Sharma, Leon Jekel, Teresa Schmidt, Jana Grieger, Giorgio Cappello, Kathrin Kizina, Lazaros Lazaridis, Laurèl Rauschenbach, Yahya Ahmadipour, Philipp Dammann, Andreas Junker, Kathy Keyvani, Jonas Feldheim, Daniela Pierscianek, Björn Scheffler, Martin Proescholdt, Peter Hau, Anca-Ligia Grosu, Dietmar Krex, Ulrich Sure, Christoph Kleinschnitz, Christoph Pöttgen, Martin Stuschke, Martin Glas

Open source

DOI
10.1186/s12885-026-16613-y
Published
2026-07-27
Container
BMC Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16613-y,
  title = {Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF)},
  author = {Sied Kebir and Christoph Oster and Sandeep Sharma and Leon Jekel and Teresa Schmidt and Jana Grieger and Giorgio Cappello and Kathrin Kizina and Lazaros Lazaridis and Laurèl Rauschenbach and Yahya Ahmadipour and Philipp Dammann and Andreas Junker and Kathy Keyvani and Jonas Feldheim and Daniela Pierscianek and Björn Scheffler and Martin Proescholdt and Peter Hau and Anca-Ligia Grosu and Dietmar Krex and Ulrich Sure and Christoph Kleinschnitz and Christoph Pöttgen and Martin Stuschke and Martin Glas},
  year = {2026},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-026-16613-y},
  url = {https://doi.org/10.1186/s12885-026-16613-y}
}

RIS

TY  - JOUR
TI  - Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF)
AU  - Sied Kebir
AU  - Christoph Oster
AU  - Sandeep Sharma
AU  - Leon Jekel
AU  - Teresa Schmidt
AU  - Jana Grieger
AU  - Giorgio Cappello
AU  - Kathrin Kizina
AU  - Lazaros Lazaridis
AU  - Laurèl Rauschenbach
AU  - Yahya Ahmadipour
AU  - Philipp Dammann
AU  - Andreas Junker
AU  - Kathy Keyvani
AU  - Jonas Feldheim
AU  - Daniela Pierscianek
AU  - Björn Scheffler
AU  - Martin Proescholdt
AU  - Peter Hau
AU  - Anca-Ligia Grosu
AU  - Dietmar Krex
AU  - Ulrich Sure
AU  - Christoph Kleinschnitz
AU  - Christoph Pöttgen
AU  - Martin Stuschke
AU  - Martin Glas
PY  - 2026
JO  - BMC Cancer
DO  - 10.1186/s12885-026-16613-y
UR  - https://doi.org/10.1186/s12885-026-16613-y
ER  - 

APA

Kebir, S., Oster, C., Sharma, S., Jekel, L., Schmidt, T., Grieger, J., Cappello, G., Kizina, K., Lazaridis, L., Rauschenbach, L., Ahmadipour, Y., Dammann, P., Junker, A., Keyvani, K., Feldheim, J., Pierscianek, D., Scheffler, B., Proescholdt, M., Hau, P., Grosu, A., Krex, D., Sure, U., Kleinschnitz, C., Pöttgen, C., Stuschke, M., & Glas, M. (2026). Safety and feasibility of tumor treating fields initiated before and during radiotherapy for newly diagnosed glioblastoma: results from the Arm A feasibility cohort of a phase I/II trial (PriCoTTF). BMC Cancer. https://doi.org/10.1186/s12885-026-16613-y

Source records